- Adolescent patients provide a unique opportunity within the pediatric population to evaluate the clinical utility of diagnostic exome sequencing (DES) in undiagnosed individuals with neurodevelopmental disorders (NDD)
- We report the detection rates and findings of 568 adolescents with NDD undergoing DES
- Positive or likely positive findings were identified in 106 individuals (19%) in 106 characterized genes; 66% (70/106) of these genes are not included in a large routine neurodevelopmental MGPT
- Identification of a genetic etiology has important treatment, management, and reproductive implications as these patients transition into adulthood